Baylor Health Care System
 
2 4 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drug-induced immune hemolytic anemia

Alternative Names

Immune hemolytic anemia secondary to drugs; Anemia - immune hemolytic - secondary to drugs

Prevention

You should continue to avoid the drug that caused this condition.

References

Vandendries ER. Drug-associated disease: hematologic dysfunction. Crit Care Clin. April 2006; 22(2): 347-55, viii.

Dhaliwal G. Hemolytic anemia. Am Fam Physician. June 2004; 69(11): 2599-606.

Kasper D, Braunwald E, Fauci A, et al. Harrison's Principals of Internal Medicine. 16th edition [online version]. New York, NY: McGraw Hill; 2005.

Review Date: 4/1/2007
Reviewed By: Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission. URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2005 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.